Bupropion and Naltrexone for Weight Loss
Links shared publicly online about this topic
COR-I: naltrexone/bupropion combo as obesity drug | theheart.org
theheart.org — “New randomized trial results suggest the combination of two” View full resource at theheart.org
Most Recently Shared on July 29, 2010 at 10:36 pm By:
COR-I: Combo drug leads to significant weight loss, but CV effects questioned: New randomized trial results sugges... http://bit.ly/bMzyaY
Comparison of combined bupropion and naltrexone th... [J Clin Endocrinol Metab. 2009] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 18 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on January 8, 2010 at 3:48 pm By:
William Yates, M.D. Psychiatrist, Family Medicine Doctor, Physician, and Doctor
Naltrexone/bupropion combo therapy effective for weight loss in randomized clinical trial. http://ow.ly/UeQY
Effect of naltrexone plus bupropion on weight loss... [Lancet. 2010] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on August 30, 2010 at 2:18 pm By:
Zack (Sholem) Berger Physician, Doctor, and Internist
Moderately effective medical therapy for #obesity in good-quality trial: bupropion + naltrexone. http://bit.ly/9wSqCT
Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial : The Lancet
thelancet.com — “Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. By - Prof Frank L Greenway MD,...” View full resource at thelancet.com
Most Recently Shared on August 22, 2010 at 1:41 am By:
Symposier Endocrino Health Site
Combination Weight Loss Drugs Appear Effective for Obesity. http://bit.ly/cjn0cN
Combo Weight Loss Pill Fights Cravings and Appetite
webmd.com — “An experimental obesity drug reduces body weight by 5% or more after one year when combined with healthy diet and regular exercise.” View full resource at webmd.com
Most Recently Shared on July 29, 2010 at 11:18 pm By:
webMD: Combo Weight Loss Pill Fights Cravings and Appetite http://bit.ly/b6irB8 Full http://bit.ly/beSNIP
FDA Says No to Weight-Loss Combo Drug Contrave - ABC News
abcnews.go.com — “A pill combining bupropion and naltrexone for weight loss (Contrave) won't receive the FDA's approval until its manufacturer, Orexigen, conducts a new clinical trial evaluating its cardiovascular risks, the company said.” View full resource at abcnews.go.com
Most Recently Shared on February 5, 2011 at 1:27 pm By:
FDA Says No to Weight-Loss Combo Drug http://bit.ly/gAs5L8
Medical News: FDA Says No to Weight-Loss Combo Drug - in Primary Care, Obesity from MedPage Today
medpagetoday.com — “A pill combining bupropion and naltrexone for weight loss (Contrave) won't receive the FDA's approval until its manufacturer, Orexigen, conducts a new clinical trial evaluating its cardiovascular risk” View full resource at medpagetoday.com
Most Recently Shared on February 1, 2011 at 5:39 pm By:
Evelyn Tribole Nutritionist, Dietitian, and Active Health Library
FDA Says No to Weight-Loss Combo Drug, Contrave, which consists of bupropion and naltrexone. http://bit.ly/g6SOkp
Combination Naltrexone And Bupropion For Obesity Leads To Substantial Reductions In Bodyweight
medicalnewstoday.com — “Combination treatment for obesity using the drugs naltrexone and bupropion, plus diet and exercise, helps reduce bodyweight by a mean of 5% or more over a year, depending on the dosage used. The f” View full resource at medicalnewstoday.com
Most Recently Shared on August 3, 2010 at 11:43 am By:
Sara Stein MD Doctor, Psychiatrist, and Physician
#obesity - Good study on naltrexone & bupropion (with diet & exercise) for weight reduction - a good combination;... http://fb.me/t9suo6ZR
FDA Panel Endorses Contrave Weight-Loss Drug - ABC News
abcnews.go.com — “An FDA advisory committee has voted 13-7 that the modest weight-loss benefits of an investigational combination of naltrexone and bupropion (Contrave) outweigh the drug's blood pressure risk.” View full resource at abcnews.go.com
Most Recently Shared on December 8, 2010 at 1:23 pm By:
Dr. Stephen Sinatra Nutritionist, Physician, Doctor, Internist, and Cardiologist
FDA panel recommends diet pill despite little benefit compared to placebo and real heart risks. Thumbs down! http://ow.ly/3lTsY
FDA Says No to Weight-Loss Combo Drug - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- A pill combining bupropion and naltrexone for weight loss (Contrave) won't receive the FDA's approval until its manufacturer, Orexigen, conducts a new clinical trial evaluating its cardiovascular risks, the company said.” View full resource at qualitypointtech.net
Most Recently Shared on February 1, 2011 at 6:01 pm By:
FDA Says No to Weight-Loss Combo Drug: (MedPage Today) -- A pill combining bupropion and naltrexone for weight los... http://bit.ly/eKfeef
Medical News: Weight-Loss Combo Appears Effective - in Primary Care, Obesity from MedPage Today
medpagetoday.com — “A sustained-release formulation combining bupropion and naltrexone (Contrave) appears to be an effective treatment for weight loss in obese patients, researchers have found.” View full resource at medpagetoday.com
Most Recently Shared on July 30, 2010 at 4:37 pm By:
Weight-Loss Combo Appears Effective (CME/CE) (MedPage Today) -- A sustained-release formulation combining bupropion and.. http://dld.bz/pzez
Medical News: Weight-Loss Combo Appears Effective - in Primary Care, Obesity from MedPage Today
medpagetoday.com — “A sustained-release formulation combining bupropion and naltrexone (Contrave) appears to be an effective treatment for weight loss in obese patients, researchers have found.” View full resource at medpagetoday.com
Most Recently Shared on July 30, 2010 at 4:16 pm By:
Weight loss combo appears effective: http://bit.ly/cQIBgd
FDA panel recommends approval of weight-loss drug - - Drug Topics
drugtopics.modernmedicine.com — “An FDA panel has recommended that the agency approve Orexigen Therapeutics? and Takeda?s obesity drug Contrave (naltrexone SR/bupropion SR). This makes the drug the first in a group of competitors to receive this recommendation, the Associated Press reported.” View full resource at drugtopics.modernmedicine.com
Most Recently Shared on December 9, 2010 at 7:24 pm By:
Drugs and Devices OW OW Health
FDA panel recommends approval of weight-loss drug: An FDA panel has recommended that the agency approve ... http://bit.ly/e9UK8w #pharma
FDA panel recommends approval of weight-loss drug - - Drug Topics
drugtopics.modernmedicine.com — “An FDA panel has recommended that the agency approve Orexigen Therapeutics? and Takeda?s obesity drug Contrave (naltrexone SR/bupropion SR). This makes the drug the first in a group of competitors to receive this recommendation, the Associated Press reported.” View full resource at drugtopics.modernmedicine.com
Most Recently Shared on December 9, 2010 at 7:05 pm By:
Drugs and Devices OW OW Health
FDA panel recommends approval of weight-loss drug: An FDA panel has recommended that the agency approve Or... http://bit.ly/feGxUL #drug
Medical News: OBESITY: CVD Risk Cut With Rejected Weight-Loss Drug - in Meeting Coverage, OBESITY from MedPage Today
medpagetoday.com — “ORLANDO -- It appears that the investigational weight-loss combination of naltrexone standard release and bupropion standard release (Contrave) reduces the predicted 10-year risk of cardiovascular eve” View full resource at medpagetoday.com
Most Recently Shared on October 6, 2011 at 5:01 pm By:
Rejected weight-loss drug Contrave cuts heart risks #OBESITY2011: http://t.co/0yaqRQFA
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Shelley Wood
Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4
-
William Yates, M.D.
Clinical Neuroscientist. Research Psychiatrist, Laureate Institute of Brain Research (laureateinstitute.org) Professor of Research, University of Oklahoma.
-
Zack (Sholem) Berger
Doctor, writer, observant Jew, Yiddish poet/ideologue.
Advertisement
